Healius Ltd (ASX: HLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healius Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healius Ltd (ASX: HLS)
Latest News
Share Fallers
Why Altium, BlueBet, Healius, & HUB24 shares are tumbling lower
Earnings Results
Healius (ASX:HLS) share price sinks 10% despite 179% profit surge in FY21
⏸️ ASX Shares
Here are the 10 top moving ASX shares on Monday
Healthcare Shares
Healius (ASX:HLS) could be a potential takeover target – Expert
Broker Notes
2 more ASX 200 shares tipped to positively surprise during reporting season
52-Week Highs
These ASX 200 shares have just hit 52-week highs
Healthcare Shares
2 ASX healthcare shares that analysts think could beat the market
Broker Notes
Brokers using the lockdown to upgrade earnings forecasts on these ASX 200 shares
Broker Notes
3 ASX shares to snap up before reporting season: expert
Share Market News
ASX 200 rises, API soars, Wesfarmers up
Share Gainers
Healius (ASX:HLS) share price higher on acquisition and rebrand news
Healthcare Shares
The 5 best ASX 200 healthcare shares of financial year 2021
Frequently Asked Questions
-
Yes, Healius has historically paid two fully franked shareholder dividends a year.
-
Healius has generally paid its shareholder dividends in March/April and September/October.
-
Healius Ltd listed on the ASX on 3 July 1998.
HLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Healius Ltd
Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.
The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres.
The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics.
